Clinical trial
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
NCT00293735 · Baylor College of Medicine, Other · Withdrawn
Key facts
| NCT number | NCT00293735 |
|---|---|
| Title | Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial |
| Official title | Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET) |
| Acronym | LAMPET |
| Lead sponsor | Baylor College of Medicine, Other |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Preeclampsia, Pregnancy Induced Hypertension, Gestational Hypertension, Chronic Hypertension, Superimposed Preeclampsia |
| Intervention type | Drug |
| Interventions | labetalol (seizure prevention), MgSO4 (seizure prevention) |
| Enrollment | 0 |
| Start date | Jun 1, 2015 |
| Primary completion | Jan 1, 2017 |
| Completion | Jan 1, 2017 |
| First posted | Feb 17, 2006 |
| Last update posted | Jan 13, 2017 |
| Countries | India, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: